Lonza Small Molecules

Lonza-Small-Molecules.png

At Lonza Small Molecules, our connected experts work together to provide contract development and manufacturing services, helping pharma and small biotech companies deliver their medicines to patients in need. From the earliest stages of discovery to the final drug product, we can simplify your outsourcing experience with our reliable, timely service, anticipating risks and solving problems.

Whether you are developing a pioneering therapy or creating a new oral solid dosage form, Lonza is the only CDMO partner you need. Throughout your molecule’s journey from early development to commercial product, we work as one.

Latest Content

Related Resources

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules

White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

PBPK modeling that saves you time and money

PBPK modeling that saves you time and money

Content provided by Lonza Small Molecules

White Paper

Understanding pharmacokinetic behaviors ahead of later-stage development means making informed decisions earlier. This enhanced capability helps your drug development projects meet tight timelines and budget objectives.

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules

Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can be fraught with risk.